Skip to main content
. 2019 Nov 28;59(8):1997–2004. doi: 10.1093/rheumatology/kez557

Table 1.

Patient characteristics

Characteristics Former smokers (n = 1012) Current smokers (n = 887) Never smoked (n = 1412)
Age, mean (s.d.), years 58.77 (12.30)** 53.59 (11.72)** 55.33 (15.41)*
Sex (female), n (%) 636 (62.8)* 596 (67.2)** 1221 (86.5)**
BMI, mean (s.d.) 27.47 (4.90)** 25.95 (4.74)* 27.03 (5.13)**
Disease duration, years, median (IQR) 1.74 (0.25–10.59)** 4.22 (0.07–6.00)* 3.08 (0.45–11.00)**
RF positive, n (%) 656 (66.3)* 632 (72.3) 885 (63.9)**
Anti-CCP positive, n (%) 597 (61.0) 529 (63.3)* 766 (56.4)*
Extra-articular RA, n (%) 48 (6.3) 42 (5.9) 82 (8.1)
Statin, n (%) 111 (11.0)* 69 (7.8) 175 (12.4)**
Anti-hypertensive, n (%) 220 (21.7)** 137 (15.5) 331 (23.5)**
MTX, n (%) 398 (39.7)** 263 (29.8)* 635 (45.1)**
HCQ, n (%) 128 (12.7) 95 (10.8)** 287 (20.4)**
DMARD, n (%) 515 (51.1)** 368 (41.6)** 824 (58.5)**
Biologic, n (%) 155 (15.4)* 111 (12.6) 250 (17.8)**
Steroids, n (%) 240 (23.8) 215 (24.3)* 412 (29.3)*
*

P < 0.05,

**

P < 0.001.